Co-Diagnostics revamps COVID-19 test for FDA clearance amid stability concerns
Co-Diagnostics, Inc. has announced that it is withdrawing its 510(k) clearance application for its Co-Dx PCR COVID-19 test following discussions with the Food and Drug ... Read More
Understanding and Combating Tuberculosis: A Comprehensive Guide
Tuberculosis (TB) remains one of the most persistent and deadly infectious diseases globally. Caused by various strains of the Mycobacterium tuberculosis bacteria, TB primarily targets ... Read More
Lupin partners with procurement agencies for TB prevention treatment
Lupin Limited has entered into partnerships with Unitaid, the Clinton Health Access Initiative (CHAI), The Aurum Institute, and other global procurement agencies for supporting tuberculosis ... Read More
Lupin, TB Alliance partner for new therapy for highly drug-resistant TB
Indian pharma company Lupin Limited has secured a non-exclusive license from TB Alliance, a non-profit drug developer, for manufacturing the anti-TB drug pretomanid. Pretomanid is ... Read More
PerkinElmer to acquire Oxford Immunotec for $591m to expand tuberculosis testing capabilities
In a significant move within the diagnostics sector, US-based PerkinElmer has announced its agreement to acquire UK-based Oxford Immunotec for $591 million, translating to $22 ... Read More
LIAISON QFT-Plus automated screening solution gets FDA nod for TB detection
Qiagen and DiaSorin have secured approval from the US Food and Drug Administration (FDA) to use QuantiFERON-TB Plus (QFT-Plus automated screening solution) on the latter’s ... Read More